Healthcare -
Biotechnology - NASDAQ - BM
$ 21.98
8.38 %
$ 1.6 B
Market Cap
-36.63
P/E
KNSA - CASH & EQUIVALENTS
Cash & Equivalents KNSA - Kiniksa Pharmaceuticals, Ltd.
108 M
LAST VALUE
-6.11%
2 YEAR CAGR
-18.88%
5 YEAR CAGR
0.00%
10 YEAR CAGR